Table 3 Adverse events
In-line filter group | Control group | p value | |
|---|---|---|---|
n | 252 | 252 | |
New candida bloodstream infection (n/%) | 0 (0) | 2 (0.8) | 0.5 |
New central-line-associated bloodstream infection (n/%) | 1 (0.4) | 1 (0.4) | 1 |
New thromboembolic event (n/%) | 1 (0.4) | 3 (1.2) | 0.62 |
Patients with hyperglycemia (n/%) | 109 (43.3) | 121 (48) | 0.33 |
Insulin therapy (n/%) | 91 (36.1) | 104 (41.3) | 0.27 |
Cumulative insulin dose (IU) | 58 (18–136) | 53 (22–207) | 0.95 |
Patients with hypoglycemia (n/%) | 27 (10.7) | 19 (7.5) | 0.28 |